Who Owns MusclePharm Corp. Company?

MusclePharm Corp. Bundle

Get Full Bundle:

	5 FORCES	$15	$10
	BCG	$15	$10
	CANVAS	$15	$10
	4P's MIX	$15	$10
	PESTLE	$15	$10
	SWOT	$15	$10

TOTAL:

ADD TO CART

Who Owns MusclePharm Corp.?

Understanding MusclePharm's ownership is key to grasping its market strategy. A major shift occurred in October 2023 when FitLife Brands acquired the company for $18.5 million.

This acquisition marked a significant change in MusclePharm's ownership structure, impacting its direction in the competitive supplement industry.

The ownership of MusclePharm Corporation is now primarily with FitLife Brands, following their acquisition in October 2023. Previously, MusclePharm was a publicly traded entity. This transition under FitLife Brands is a crucial point for understanding its current operational framework and future plans, including its product lines like MusclePharm Corp. Porter's Five Forces Analysis.

MusclePharm Corporation's origins trace back to Denver, Colorado, in 2008, founded by former professional football player Brad Pyatt. Pyatt envisioned a company focused on science-backed nutritional supplements, aiming to elevate product quality in a market often perceived as unreliable. The company was initially incorporated in Nevada on August 4, 2006, as 'Tone in Twenty' before acquiring Muscle Pharm, LLC on February 18, 2010. This acquisition involved issuing 26,000,000 shares of common stock, representing approximately 99.4% of outstanding shares post-closing.

Founding Vision

Brad Pyatt, leveraging his background as a professional athlete, aimed to create high-quality, science-backed sports nutrition products.

Corporate Evolution

The company began as 'Tone in Twenty' in 2006 before acquiring Muscle Pharm, LLC in 2010, becoming a wholly-owned subsidiary.

Early Funding

Initial funding came from the founder and early seed investments, with The Frost Group, LLC being a notable early backer.

Key Early Investor

The Frost Group, led by Phillip Frost, invested significantly, including a lead role in a 2013 registered direct offering totaling $2.9 million.

Ownership Structure

The early ownership structure was shaped by the founding team's vision and the distribution of control among key individuals and early investors.

Founders' Roles

Brad Pyatt was instrumental as the initial CEO, while Cory Gregory served as co-founder and president until mid-2012.

The early ownership of MusclePharm Corporation was primarily influenced by its founders, Brad Pyatt and Cory Gregory, and significant early investors like The Frost Group, LLC. Pyatt's vision as a former professional athlete guided the company's focus on scientifically validated supplements. Cory Gregory also played a crucial role as a co-founder and president. The company's structure was solidified through the acquisition of Muscle Pharm, LLC, which involved a substantial share issuance, indicating a strong initial ownership stake by the acquired entity's stakeholders. Early funding rounds, including a notable registered direct offering in 2013 where The Frost Group increased its investment to $2.9 million, were critical in establishing the company's financial foundation and influencing its early ownership dynamics.

Early Ownership Dynamics

The initial MusclePharm ownership was a blend of founder equity and investment from key financial backers, shaping the company's trajectory.

• Brad Pyatt, a former professional athlete, co-founded MusclePharm.
• Cory Gregory was also a co-founder and served as president.
• The company was incorporated as 'Tone in Twenty' in 2006.
• Muscle Pharm, LLC was acquired in 2010, involving a significant share issuance.
• The Frost Group, LLC was a key early investor, contributing substantial capital.
• Early investments were crucial for establishing the brand in the sports nutrition market.

MusclePharm Corp. SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

MusclePharm Corporation's ownership has seen a significant shift, moving from a publicly traded entity to a subsidiary following an asset acquisition. This transition has reshaped its stakeholder landscape and operational control.

The acquisition by FitLife Brands in October 2023 for $18.5 million, approved by the U.S. Bankruptcy Court for the District of Nevada, marked a pivotal moment in MusclePharm's history. This transaction effectively transitioned MusclePharm from its previous status as a publicly traded company to an operating subsidiary of FitLife Brands, a company focused on nutritional supplements and wellness products. This move aimed to leverage FitLife Brands' expertise to expand distribution and introduce new products, particularly through online channels and the restoration of wholesale distribution.

MusclePharm's Evolving Shareholder Base

MusclePharm's ownership structure has evolved significantly, with a notable absence of institutional investors in recent filings and a history of substantial individual holdings.

• As of January 15, 2025, MusclePharm Corp (US:MSLP) reported 0 institutional owners and shareholders who had filed 13D/G or 13F forms with the SEC.
• Historically, individuals like Barry Honig and entities such as GRQ Consultants, Inc. held significant stakes, with beneficial ownership of 5.83% and 5.64% respectively as of April 11, 2013.
• Other past investors included Amerop Holdings, Iconic Private Equity Partners, Indy MD Angels, Magna Management, and Prestige Capital.
• The acquisition by FitLife Brands has consolidated ownership, making MusclePharm a subsidiary rather than a publicly traded entity with a broad shareholder base.
• Understanding the Marketing Strategy of MusclePharm Corp. is key to appreciating its business trajectory and potential future ownership dynamics.

MusclePharm Corp. PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

Following its acquisition by FitLife Brands in October 2023, MusclePharm Corporation now operates as a subsidiary, with its governance and voting power primarily influenced by FitLife Brands. The previous independent board structure has been integrated into FitLife Brands' corporate framework.

Prior to its acquisition, MusclePharm Corporation's board of directors played a key role in its governance. As of July 8, 2019, the board included Ryan Charles Drexler as Executive Chairman, President, CEO, CFO & CAO, alongside directors John J. Desmond, Brian Casutto (also Executive VP-Sales & Operations), and William John Bush as an Independent Director. Ryan Drexler, through Consac, LLC, held substantial voting power. Historically, MusclePharm's common stock operated on a one-share-one-vote basis. For example, on April 18, 2011, with 148,320,775 shares outstanding, each share carried one vote. A quorum required a majority of outstanding shares, and proposals were passed by a majority vote within that quorum. Leadership changes occurred over time; Brad Pyatt, a co-founder and former CEO, resigned in March 2016, with Ryan Drexler stepping in as Interim CEO and President. Earlier, in July 2012, co-founder Cory Gregory stepped down from the board but remained president. The acquisition by FitLife Brands in October 2023 marked a significant shift, integrating MusclePharm into FitLife's corporate structure. Dayton Judd, Chairman and CEO of FitLife Brands, has highlighted the anticipated positive impact of this acquisition on FitLife's revenue and earnings growth.

MusclePharm's Evolving Ownership and Governance

MusclePharm's ownership and board structure have undergone significant transformations, particularly with its recent acquisition. Understanding these changes is crucial for grasping the current MusclePharm company structure.

• Ryan Charles Drexler held key executive and board positions prior to the acquisition.
• Consac, LLC, associated with Ryan Drexler, was a significant voting power holder.
• The company historically operated on a one-share-one-vote system.
• MusclePharm is now a subsidiary of FitLife Brands, impacting its corporate governance.
• The Target Market of MusclePharm Corp. remains a key consideration for its strategic direction under new ownership.

MusclePharm Corp. Business Model Canvas

• Complete 9-Block Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready BMC Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

The ownership landscape of MusclePharm Corporation has undergone a significant transformation in recent years, culminating in its acquisition by FitLife Brands, Inc. in October 2023. This pivotal event transitioned MusclePharm from a publicly traded entity to an operating subsidiary, marking a new chapter in its corporate history.

Prior to its acquisition, MusclePharm Corporation experienced a period of financial and regulatory challenges. The company had been listed on the OTCQB under the ticker MSLP, with a market capitalization around $6 million in 2022. An attempt to uplist to Nasdaq in June 2022, aiming to raise up to $10 million, was ultimately withdrawn. Furthermore, the company faced SEC charges concerning accounting and disclosure violations dating back to 2015, with former executives being charged in June 2023. As of July 31, 2024, MusclePharm was delinquent in its SEC filings, having not submitted periodic reports since March 31, 2022, which impacts its transparency for potential investors and stakeholders interested in MusclePharm ownership.

Post-Acquisition Performance

In Q1 2025, the MusclePharm segment within FitLife Brands reported just under $2.0 million in revenue. This represents a 6% year-over-year decrease for the segment.

FitLife Brands' Strategy

FitLife Brands aims to revitalize the MusclePharm brand through increased online direct-to-consumer sales and expanded wholesale distribution. Restoring previous retail partnerships is a key focus.

Market Context

This acquisition aligns with a broader trend of consolidation in the nutritional supplements market. Companies are acquiring niche brands to broaden their product offerings and market reach.

Market Growth Projections

The global protein supplements market is projected to grow from $22.25 billion in 2024 to $24.28 billion in 2025. The broader nutritional supplements market is expected to grow from $414.85 billion in 2024 to $444.98 billion in 2025.

MusclePharm Corp. Porter's Five Forces Analysis

• Covers All 5 Competitive Forces in Detail
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔